Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity (SELECT)
SELECT - Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity
Sponsor: Novo Nordisk A/S
A PHASE3 clinical study on Obesity and Overweight, this trial is completed. The trial is conducted by Novo Nordisk A/S and has accumulated 54 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
54 versions recorded-
Jan 2026 — Present [monthly]
Completed PHASE3
-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
May 2024 — Jul 2024 [monthly]
Completed PHASE3
▶ Show 49 earlier versions
-
Mar 2024 — May 2024 [monthly]
Completed PHASE3
-
Feb 2024 — Mar 2024 [monthly]
Completed PHASE3
-
Jan 2024 — Feb 2024 [monthly]
Completed PHASE3
-
Nov 2023 — Jan 2024 [monthly]
Completed PHASE3
-
Sep 2023 — Nov 2023 [monthly]
Completed PHASE3
-
Aug 2023 — Sep 2023 [monthly]
Completed PHASE3
-
Jul 2023 — Aug 2023 [monthly]
Completed PHASE3
Status: Recruiting → Completed
-
Jun 2023 — Jul 2023 [monthly]
Recruiting PHASE3
Status: Active Not Recruiting → Recruiting
-
Apr 2023 — Jun 2023 [monthly]
Active Not Recruiting PHASE3
-
Mar 2023 — Apr 2023 [monthly]
Active Not Recruiting PHASE3
-
Jan 2023 — Mar 2023 [monthly]
Active Not Recruiting PHASE3
-
Apr 2022 — Jan 2023 [monthly]
Active Not Recruiting PHASE3
-
Dec 2021 — Apr 2022 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Oct 2021 — Dec 2021 [monthly]
Recruiting PHASE3
-
Sep 2021 — Oct 2021 [monthly]
Recruiting PHASE3
-
Jun 2021 — Sep 2021 [monthly]
Recruiting PHASE3
-
May 2021 — Jun 2021 [monthly]
Recruiting PHASE3
-
Apr 2021 — May 2021 [monthly]
Recruiting PHASE3
-
Mar 2021 — Apr 2021 [monthly]
Recruiting PHASE3
-
Feb 2021 — Mar 2021 [monthly]
Recruiting PHASE3
-
Jan 2021 — Feb 2021 [monthly]
Recruiting PHASE3
-
Dec 2020 — Jan 2021 [monthly]
Recruiting PHASE3
-
Nov 2020 — Dec 2020 [monthly]
Recruiting PHASE3
-
Oct 2020 — Nov 2020 [monthly]
Recruiting PHASE3
-
Sep 2020 — Oct 2020 [monthly]
Recruiting PHASE3
-
Aug 2020 — Sep 2020 [monthly]
Recruiting PHASE3
-
Jul 2020 — Aug 2020 [monthly]
Recruiting PHASE3
-
Jun 2020 — Jul 2020 [monthly]
Recruiting PHASE3
-
May 2020 — Jun 2020 [monthly]
Recruiting PHASE3
-
Apr 2020 — May 2020 [monthly]
Recruiting PHASE3
-
Mar 2020 — Apr 2020 [monthly]
Recruiting PHASE3
-
Feb 2020 — Mar 2020 [monthly]
Recruiting PHASE3
-
Jan 2020 — Feb 2020 [monthly]
Recruiting PHASE3
-
Dec 2019 — Jan 2020 [monthly]
Recruiting PHASE3
-
Nov 2019 — Dec 2019 [monthly]
Recruiting PHASE3
-
Oct 2019 — Nov 2019 [monthly]
Recruiting PHASE3
-
Sep 2019 — Oct 2019 [monthly]
Recruiting PHASE3
-
Aug 2019 — Sep 2019 [monthly]
Recruiting PHASE3
-
Jul 2019 — Aug 2019 [monthly]
Recruiting PHASE3
-
Jun 2019 — Jul 2019 [monthly]
Recruiting PHASE3
-
May 2019 — Jun 2019 [monthly]
Recruiting PHASE3
-
Apr 2019 — May 2019 [monthly]
Recruiting PHASE3
-
Mar 2019 — Apr 2019 [monthly]
Recruiting PHASE3
-
Feb 2019 — Mar 2019 [monthly]
Recruiting PHASE3
-
Jan 2019 — Feb 2019 [monthly]
Recruiting PHASE3
-
Dec 2018 — Jan 2019 [monthly]
Recruiting PHASE3
-
Nov 2018 — Dec 2018 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Oct 2018 — Nov 2018 [monthly]
Not Yet Recruiting PHASE3
-
Aug 2018 — Oct 2018 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Novo Nordisk A/S
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
A Coruña, Spain , Aachen, Germany , Aalborg, Denmark , Aalst, Belgium , Aarhus N, Denmark , Adachi-ku, Tokyo, Japan , Adana, Turkey (Türkiye) , Addlestone, United Kingdom , Adelaide, Australia , Aguascalientes, Mexico and 598 more locations